Skip to content

Validation study on the effects on liver function and skin barrier function by intake of adlay

Validation study on the effects on liver function and skin barrier function by intake of adlay - Validation study on the effects on liver function and skin barrier function by intake of adlay

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000041108
Enrollment
70
Registered
2020-07-15
Start date
2020-08-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Intake 500mL of adlay tea daily for 8 weeks. Intake 500ml of barley tea daily for 8 weeks.

Sponsors

Healthcare Systems Co., Ltd.
Lead Sponsor
Oyama city
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1.Persons who received a sufficient explanation of the purpose and contents of the exam, have the capacity to consent, applied with free will with sufficient understanding, and agreed to participate with a written document 2.Japanese women who are 20 years old or more and under 65 years old 3.Persons who are the bottom 70 of the value of skin hydration at screening

Exclusion criteria

Exclusion criteria: 1.Persons who have chronic illness, receiving medication, have a serious disease history 2.Persons who are allergic to the test food 3.Persons who usually take a large amount of test food 4.Persons whose ALT or AST is over 51 U/L at screening 5.Persons whose gamma-GTP is over 101 U/L at screening 6.Persons whose habitually consume higher amount of alcohol (>60g alcohol/day) 7.Persons who have skin disease such as atopic dermatitis, urticaria, eczema and dermatitis. 8.Persons who regularly use medicines, specified insurance foods, health foods, etc. that may affect liver function and skin function 9.Persons who have participated in other tests within the first month before the start of the test, or those who intend to participate in another exam after consenting to this exam 10.Persons who are pregnant, planning or hoping to be pregnant during the study period, breastfeeding 11.Persons who were judged as inappropriate for subjects by the principal investigator

Design outcomes

Primary

MeasureTime frame
-liver function (AST, ALT, gamma-GTP ) -skin hydration (Transepidermal water loss, Moisture) At the beginning of the test or after the intake for 8 weeks.

Secondary

MeasureTime frame
-Blood test (total protein, albumin, ,blood neutral fat (TG), total cholesterol, HDL-cholesterol, LDL-cholesterol, urea nitrogen , ALP, CPK, total bilirubin, uric acid, urea nitrogen, creatinine, sodium, potassium, chlorine, calcium, phosphorus, magnesium, LDH, white blood cell count, red blood cell count, hemoglobin, hematocrit, platelet count, MCV, MCH, MCHC) -Physical examination (body height, weight, BMI, blood pressure, pulse) -Food questionnaire

Countries

Japan

Contacts

Public ContactHitomi Izumi

Healthcare Systems Co., Ltd. Research and Development Department

izumi@hc-sys.jp03-6809-2722

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026